Company profileMixed portfolio#148 of 1,318 in Pakistan✓ No DRAP alerts

EURO PHARMA INTERNATIONAL

Mixed portfolio · 48 pharmaceutical brands of 115 registrations

Ranked #23 of 33 companies in Antibiotics For Topical Use

115 registered products 48 pharmaceutical brands 76 distinct molecules 0 DRAP alerts
Part of this company's portfolio (“Nutritional Supplement / Multivitamin”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

115
registered products
48
pharmaceutical brands
76
distinct molecules
2
therapeutic classes
0
DRAP alerts

EURO PHARMA INTERNATIONAL is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 115 product registrations across 76 distinct molecules. It is the 148th largest registrant in Pakistan by product count, and ranks 23rd of 33 in Antibiotics For Topical Use. Its portfolio is concentrated in Antibiotics For Topical Use and Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Nutritional Supplement / Multivitamin43 brands
Paracetamol5 brands
Thiamine5 brands
Nicotinamide5 brands
Sodium Acid4 brands
Menthol4 brands
Ampicillin4 brands
Riboflavin4 brands

Therapeutic classes

Antibiotics For Topical Use · 1Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 46.55 – Rs 46.55
Median across source: Rs 46.55

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for EURO

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.